• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[去氨加压素试验在库欣病诊断中的应用]

[The desmopressin test in the diagnosis of Cushing's disease].

作者信息

Gasińiska Teresa, Dec Renata, Wichary Hanna, Pietrasik Lidia, Kulawik Grazyna

机构信息

Katedra i Klinika Chorób Wewngtrznych i Chemioterapii Onkologicznej, Slaska Akademia Medyczna, Katowice.

出版信息

Pol Arch Med Wewn. 2007 Jan-Feb;117(1-2):20-6.

PMID:17642202
Abstract

INTRODUCTION

Early and precise diagnosis is necessary in successful treatment of the patients with Cushing's disease. Transsphenoidal surgery is the first line treatment option in Cushing's disease. In patients in whom magnetic resonance imaging does not visualise pituitary adenoma patient selection for surgical treatment should be based on convincing results of functional tests.

OBJECTIVES

The diagnostic accuracy of the desmopressin test was compared with that of the CRH test and the overnight high-dose dexamethasone suppression test in the diagnosis of Cushing's disease.

DESIGN AND METHOD

We studied 15 patients with pituitary-dependent Cushing's disease (10 with detected microadenoma and 5 with undetected microadenoma using magnetic resonance imaging). The diagnosis was confirmed during pituitary surgery. The control group included 15 subjects without Cushing's syndrome. Patients underwent tests with desmopressin, CRH and 8 mg overnight dexamethasone.

RESULTS

A false negative response to CRH was present in 1 of 15 patients, a false negative response t dexamethasone was present in 1 of 15 patients and a false negative response to desmopressin in 2 of 15 patients. In other patients positive responses to CRH, desmopressin and dexamethasone were found. A positive response to desmopressin was present in 4 of 5 patients with undetected pituitary adenoma. In the control group a positive response to CRH and dexamethazone and a negative response to desmopressin was found in all patients.

CONCLUSIONS

  1. The highest diagnostic accuracy in the diagnosis of some patients with Cushing's disease is achieved by using a desmopressin test with high-dose dexamethasone test and CRH-test. 2. The desmopressin test can be used to precisely identify healthy individuals.
摘要

引言

对于库欣病患者的成功治疗,早期和精确诊断是必要的。经蝶窦手术是库欣病的一线治疗选择。对于磁共振成像未显示垂体腺瘤的患者,手术治疗的患者选择应基于功能测试的可靠结果。

目的

比较去氨加压素试验与促肾上腺皮质激素释放激素(CRH)试验及过夜大剂量地塞米松抑制试验在库欣病诊断中的诊断准确性。

设计与方法

我们研究了15例垂体依赖性库欣病患者(10例通过磁共振成像检测到微腺瘤,5例未检测到微腺瘤)。诊断在垂体手术期间得到证实。对照组包括15名无库欣综合征的受试者。患者接受了去氨加压素、CRH和8毫克过夜地塞米松试验。

结果

15例患者中有1例对CRH出现假阴性反应,15例患者中有1例对地塞米松出现假阴性反应,15例患者中有2例对去氨加压素出现假阴性反应。在其他患者中发现对CRH、去氨加压素和地塞米松有阳性反应。5例未检测到垂体腺瘤的患者中有4例对去氨加压素有阳性反应。在对照组中,所有患者对CRH和地塞米松出现阳性反应,对去氨加压素出现阴性反应。

结论

  1. 使用去氨加压素试验、大剂量地塞米松试验和CRH试验可在某些库欣病患者的诊断中获得最高诊断准确性。2. 去氨加压素试验可用于精确识别健康个体。

相似文献

1
[The desmopressin test in the diagnosis of Cushing's disease].[去氨加压素试验在库欣病诊断中的应用]
Pol Arch Med Wewn. 2007 Jan-Feb;117(1-2):20-6.
2
The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.联合生化检测在垂体磁共振成像阴性的库欣病诊断中的应用价值
Eur J Endocrinol. 2007 Feb;156(2):241-8. doi: 10.1530/eje.1.02332.
3
The application of the combined corticotropin-releasing hormone plus desmopressin stimulation during petrosal sinus sampling is both sensitive and specific in differentiating patients with Cushing's disease from patients with the occult ectopic adrenocorticotropin syndrome.在岩下窦采血期间应用促肾上腺皮质激素释放激素联合去氨加压素刺激,在区分库欣病患者与隐匿性异位促肾上腺皮质激素综合征患者方面既敏感又特异。
J Clin Endocrinol Metab. 2007 Jun;92(6):2080-6. doi: 10.1210/jc.2006-2691. Epub 2007 Mar 13.
4
The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.去氨加压素试验在库欣综合征诊断方法中的有限价值。
Clin Endocrinol (Oxf). 2001 May;54(5):609-16. doi: 10.1046/j.1365-2265.2001.01260.x.
5
A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.使用去氨加压素和促肾上腺皮质激素释放激素的联合试验在库欣综合征鉴别诊断中的应用
J Clin Endocrinol Metab. 1997 Jan;82(1):176-81. doi: 10.1210/jcem.82.1.3674.
6
The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.地塞米松抑制促肾上腺皮质激素释放激素刺激试验及去氨加压素试验用于鉴别库欣综合征与假性库欣状态。
Clin Endocrinol (Oxf). 2007 Feb;66(2):251-7. doi: 10.1111/j.1365-2265.2006.02717.x.
7
Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.去氨加压素对促肾上腺皮质激素(ACTH)分泌过多状态下ACTH和皮质醇分泌的影响。
Clin Endocrinol (Oxf). 1997 Jun;46(6):661-8. doi: 10.1046/j.1365-2265.1997.1330954.x.
8
[Cushing's disease with negative imaging in adults].
Ann Endocrinol (Paris). 2013 Oct;74 Suppl 1:S23-32. doi: 10.1016/S0003-4266(13)70018-0.
9
The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome.促肾上腺皮质激素释放激素试验是鉴别库欣综合征中垂体性与异位促肾上腺皮质激素分泌最可靠的非侵入性方法。
Clin Endocrinol (Oxf). 2003 Jun;58(6):718-24. doi: 10.1046/j.1365-2265.2003.01776.x.
10
Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.小剂量地塞米松抑制试验在库欣综合征诊断及鉴别诊断中的鉴别价值
J Clin Endocrinol Metab. 2003 Nov;88(11):5299-306. doi: 10.1210/jc.2003-030510.

引用本文的文献

1
Recognition and Management of Ectopic ACTH Secreting Tumors.异位促肾上腺皮质激素分泌肿瘤的识别与管理
J Endocr Soc. 2025 Feb 3;9(2):bvae194. doi: 10.1210/jendso/bvae194. eCollection 2025 Jan 6.